CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Brinzolamide and timolol maleate suspension

Last Updated: August 28, 2009
Result type: Reports
Project Number: SR0173-000
Product Line: Reimbursement Review

Generic Name: Brinzolamide and timolol maleate suspension

Brand Name: Azarga

Manufacturer: Alcon Canada Inc.

Therapeutic Area: Glaucoma and ocular hypertension

Indications: Glaucoma and ocular hypertension

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: February 18, 2010

Recommendation Type: List in a similar manner to other drugs in class